Use of barbiturates and benzodiazepines in treatment of epilepsy.Neurol Clin. 1986 Aug; 4(3):617-32.NC
Abstract
Barbiturates and benzodiazepines may be very effective in controlling seizures, especially status epilepticus. However, their chronic use may be associated with serious sedative-hypnotic effects that interfere with cognitive function and behavior. When utilized, patients must be carefully monitored to be certain that these side effects are not occurring.
MeSH
Pub Type(s)
Comparative Study
Journal Article
Review
Language
eng
PubMed ID
3528811
Citation
Vining, E P.. "Use of Barbiturates and Benzodiazepines in Treatment of Epilepsy." Neurologic Clinics, vol. 4, no. 3, 1986, pp. 617-32.
Vining EP. Use of barbiturates and benzodiazepines in treatment of epilepsy. Neurol Clin. 1986;4(3):617-32.
Vining, E. P. (1986). Use of barbiturates and benzodiazepines in treatment of epilepsy. Neurologic Clinics, 4(3), 617-32.
Vining EP. Use of Barbiturates and Benzodiazepines in Treatment of Epilepsy. Neurol Clin. 1986;4(3):617-32. PubMed PMID: 3528811.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Use of barbiturates and benzodiazepines in treatment of epilepsy.
A1 - Vining,E P,
PY - 1986/8/1/pubmed
PY - 1986/8/1/medline
PY - 1986/8/1/entrez
SP - 617
EP - 32
JF - Neurologic clinics
JO - Neurol Clin
VL - 4
IS - 3
N2 - Barbiturates and benzodiazepines may be very effective in controlling seizures, especially status epilepticus. However, their chronic use may be associated with serious sedative-hypnotic effects that interfere with cognitive function and behavior. When utilized, patients must be carefully monitored to be certain that these side effects are not occurring.
SN - 0733-8619
UR - https://www.unboundmedicine.com/medline/citation/3528811/Use_of_barbiturates_and_benzodiazepines_in_treatment_of_epilepsy_
DB - PRIME
DP - Unbound Medicine
ER -
Latest evidence on COVID-19 from PubMed, WHO, CDC.
Visit free Relief Central.
Visit free Relief Central.
Try the Free App:
